Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Celltrion | Seoul | Healthcare | Biotechnology & Medical Research | ₩38.58T | 70.9x | 67.57 | ₩175,000 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.2% Upside | Upgrade to Pro+ | |
Peptron | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩8.24T | -187.2x | 13.7 | ₩353,500 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
LigaChem Biosciences | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩5.67T | 203.3x | 1.61 | ₩156,300 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.6% Upside | Upgrade to Pro+ | |
ABL Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩4.77T | -50.5x | 0.8 | ₩87,400 | 7.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -7.3% Downside | Upgrade to Pro+ | |
TissueGene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.2T | -94.3x | 0.98 | ₩39,250 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Voronoi | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩2.21T | -41.9x | 18.97 | ₩122,700 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seegene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.29T | 147.1x | 0.3 | ₩27,900 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GI Innovation | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.17T | -17x | -34.1 | ₩19,010 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OliX Pharmaceuticals | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.16T | -15.7x | 0.24 | ₩57,700 | 5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curiox BioSystems | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩877.63B | -44x | 9.08 | ₩54,300 | 5.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NKMAX | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩684.87B | -0.12 | ₩3,685 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Orum Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩534.1B | -19.2x | 0.37 | ₩25,350 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curocell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩524.88B | -12.3x | ₩36,500 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
AprilBio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩485.47B | 17.4x | 0.08 | ₩21,550 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
JS Link | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩471.29B | -12.8x | 0.16 | ₩16,960 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genomictree | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩408.32B | -28.5x | -1.62 | ₩17,010 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SillaJen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩400.58B | -15x | -3.96 | ₩2,900 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ImmuneOncia Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩396.88B | -50.5x | 0.42 | ₩5,370 | 4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intocell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩386.04B | -59.8x | -0.89 | ₩26,000 | 3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bioneer | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩371.67B | -19.5x | 0.23 | ₩14,400 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medipost | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩343.72B | -5.3x | 0 | ₩10,080 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nibec | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩289.99B | -27.7x | ₩25,650 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Onconic Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩273.83B | ₩24,750 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
ToolGen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩266.84B | 36x | 0.33 | ₩31,100 | 4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rokit Healthcare | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩238.93B | -15x | 0.75 | ₩15,500 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmAbcine | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩233.76B | -0.66 | ₩2,915 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Bridge Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩233.56B | -1.9x | -0.2 | ₩2,820 | 7.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genexine | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩226.03B | -3.7x | ₩4,970 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
AptaBio Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩223.38B | -7.1x | 0.07 | ₩8,310 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vaxcell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩219.08B | ₩9,420 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Amicogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩210.49B | -3.8x | 0.11 | ₩3,840 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GeneOne Life Science | Seoul | Healthcare | Biotechnology & Medical Research | ₩202.03B | -4.4x | -0.11 | ₩2,385 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OrganoidSciences | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩200.24B | -11x | -0.22 | ₩30,550 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
3Billion | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩195.4B | -34.5x | 2.03 | ₩6,160 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Prestige Biopharma | Seoul | Healthcare | Biotechnology & Medical Research | ₩188.94B | 32.8x | 0.06 | ₩15,720 | 10.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abion | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩188.52B | -2.6x | 0.12 | ₩6,400 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Macrogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩172.6B | -20.7x | -0.35 | ₩15,920 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HEM Pharma | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩141.37B | ₩20,000 | 5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Medpacto | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩140.87B | -9.2x | -0.15 | ₩4,110 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CJ Bioscience | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩130B | -3x | 0.74 | ₩9,950 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tiumbio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩128.74B | -6.6x | 0.43 | ₩4,750 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
iNtRON Biotechnology | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩126.61B | -31x | -0.59 | ₩4,005 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ENCell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩123.74B | -7.1x | 0.04 | ₩11,350 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellid | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩119.93B | ₩4,065 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Neoimmunetech | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩118.25B | -0.11 | ₩1,196 | 3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
HLB BioStep | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩116.4B | -16.8x | 0.08 | ₩1,378 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dx Vx | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩113.2B | -1.7x | 0.3 | ₩2,300 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OnCoCross | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩112.13B | -19x | 1.14 | ₩9,330 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GL Pharm Tech | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩92.74B | -141.7x | -1.54 | ₩1,201 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cell Biotech | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩87.88B | 6.5x | 0.06 | ₩12,840 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |